DE69318567D1 - Kalzium-kanal-blockierende polypeptide aus theraphosidae aphonopelma - Google Patents

Kalzium-kanal-blockierende polypeptide aus theraphosidae aphonopelma

Info

Publication number
DE69318567D1
DE69318567D1 DE69318567T DE69318567T DE69318567D1 DE 69318567 D1 DE69318567 D1 DE 69318567D1 DE 69318567 T DE69318567 T DE 69318567T DE 69318567 T DE69318567 T DE 69318567T DE 69318567 D1 DE69318567 D1 DE 69318567D1
Authority
DE
Germany
Prior art keywords
calcium channel
channel blocking
polypeptide made
blocking polypeptide
theraphosidae aphonopelma
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69318567T
Other languages
English (en)
Other versions
DE69318567T2 (de
Inventor
Deane Nason
Douglas Phillips
Nicholas Saccomano
Robert VOLKMANN
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shire NPS Pharmaceuticals Inc
Pfizer Inc
Original Assignee
Pfizer Inc
NPS Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc, NPS Pharmaceuticals Inc filed Critical Pfizer Inc
Publication of DE69318567D1 publication Critical patent/DE69318567D1/de
Application granted granted Critical
Publication of DE69318567T2 publication Critical patent/DE69318567T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43513—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from arachnidae
    • C07K14/43518—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from arachnidae from spiders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Insects & Arthropods (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Neurosurgery (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Materials For Medical Uses (AREA)
  • Jellies, Jams, And Syrups (AREA)
DE69318567T 1992-11-03 1993-09-28 Kalzium-kanal-blockierende polypeptide aus theraphosidae aphonopelma Expired - Fee Related DE69318567T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US97332392A 1992-11-03 1992-11-03
PCT/US1993/009069 WO1994010196A1 (en) 1992-11-03 1993-09-28 Calcium channel blocking polypeptides from theraphosidae aphonopelma

Publications (2)

Publication Number Publication Date
DE69318567D1 true DE69318567D1 (de) 1998-06-18
DE69318567T2 DE69318567T2 (de) 1998-09-10

Family

ID=25520754

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69318567T Expired - Fee Related DE69318567T2 (de) 1992-11-03 1993-09-28 Kalzium-kanal-blockierende polypeptide aus theraphosidae aphonopelma

Country Status (21)

Country Link
EP (1) EP0668872B1 (de)
JP (1) JP2667578B2 (de)
KR (1) KR950704352A (de)
CN (1) CN1033330C (de)
AT (1) ATE166067T1 (de)
AU (1) AU668430B2 (de)
BR (1) BR9307363A (de)
CA (1) CA2148504A1 (de)
CZ (1) CZ283548B6 (de)
DE (1) DE69318567T2 (de)
DK (1) DK0668872T3 (de)
FI (1) FI934847A (de)
HU (1) HUT66075A (de)
IL (1) IL107434A0 (de)
NO (1) NO951691D0 (de)
NZ (1) NZ256767A (de)
PL (1) PL308668A1 (de)
RU (1) RU2120945C1 (de)
TW (1) TW272196B (de)
WO (1) WO1994010196A1 (de)
ZA (1) ZA938165B (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6624288B1 (en) * 1997-12-16 2003-09-23 Cognetix, Inc. Gamma-conopeptides
NZ621552A (en) * 2011-08-24 2016-12-23 Univ Queensland Pest-controlling agents isolated from spider venom and uses thereof
CZ202251A3 (cs) * 2022-02-02 2023-04-12 Ego 93 S.R.O. Senzibilační roztok a způsob jeho přípravy

Also Published As

Publication number Publication date
CZ283548B6 (cs) 1998-04-15
DK0668872T3 (da) 1998-10-07
NO951691L (no) 1995-05-02
RU2120945C1 (ru) 1998-10-27
CN1090289A (zh) 1994-08-03
EP0668872B1 (de) 1998-05-13
FI934847A (fi) 1994-05-04
IL107434A0 (en) 1994-01-25
BR9307363A (pt) 1999-05-11
JP2667578B2 (ja) 1997-10-27
TW272196B (de) 1996-03-11
NZ256767A (en) 1996-10-28
EP0668872A1 (de) 1995-08-30
WO1994010196A1 (en) 1994-05-11
HUT66075A (en) 1994-09-28
NO951691D0 (no) 1995-05-02
JPH07508758A (ja) 1995-09-28
PL308668A1 (en) 1995-08-21
FI934847A0 (fi) 1993-11-02
CZ112695A3 (en) 1995-11-15
CA2148504A1 (en) 1994-05-11
KR950704352A (ko) 1995-11-20
ZA938165B (en) 1995-05-02
RU95109941A (ru) 1997-01-10
DE69318567T2 (de) 1998-09-10
CN1033330C (zh) 1996-11-20
AU668430B2 (en) 1996-05-02
ATE166067T1 (de) 1998-05-15
AU5164293A (en) 1994-05-24

Similar Documents

Publication Publication Date Title
MY131356A (en) Calcium channel blocking polypeptide from agelenopsis aperta
MY108890A (en) Calcium channel blocking polypeptides from filistata hibernalis
DE69318567T2 (de) Kalzium-kanal-blockierende polypeptide aus theraphosidae aphonopelma
CA2146367A1 (en) Calcium channel blocking polypeptides from heteropoda venatoria
ES2075796B1 (es) Polipeptido de la agelenopsis aperta bloqueante de los canales de ca lcio

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee